We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:
MAIA Biotechnology, Inc. (MAIA - Free Report) : This immuno-oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.4% over the last 60 days.
Byrna Technologies Inc. (BYRN - Free Report) : This non-lethal defense technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 25% overthe last 60 days.
OncoCyte Corporation : This precision diagnostics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.3% over the last 60 days.
Image: Bigstock
Best Momentum Stocks to Buy for May 6th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:
MAIA Biotechnology, Inc. (MAIA - Free Report) : This immuno-oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.4% over the last 60 days.
MAIA Biotechnology, Inc. Price and Consensus
MAIA Biotechnology, Inc. price-consensus-chart | MAIA Biotechnology, Inc. Quote
MAIA’s shares gained 0.5% over the last three months compared with the S&P 500’s decline of 5.6%. The company possesses a Momentum Score of A.
MAIA Biotechnology, Inc. Price
MAIA Biotechnology, Inc. price | MAIA Biotechnology, Inc. Quote
Byrna Technologies Inc. (BYRN - Free Report) : This non-lethal defense technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 25% overthe last 60 days.
Byrna Technologies Inc. Price and Consensus
Byrna Technologies Inc. price-consensus-chart | Byrna Technologies Inc. Quote
Byrna’s shares gained 33.8% over the last six months compared with the S&P 500’s decline of 4.7%. The company possesses a Momentum Score of B.
Byrna Technologies Inc. Price
Byrna Technologies Inc. price | Byrna Technologies Inc. Quote
OncoCyte Corporation : This precision diagnostics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.3% over the last 60 days.
OncoCyte Corporation Price and Consensus
OncoCyte Corporation price-consensus-chart | OncoCyte Corporation Quote
OncoCyte’s shares gained 45.3% over the last three months compared with the S&P 500’s decline of 5.6%. The company possesses a Momentum Score of B.
OncoCyte Corporation Price
OncoCyte Corporation price | OncoCyte Corporation Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.